http://orcid.org/0000-0002-3081-8378
References
- Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Janni J, Boer MD. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 7:e35671.10.1371/journal.pone.0035671
- Bekele B, Adane L, Tariku Y, Hailu A. 2013. Evaluation of antileishmanial activities of triglycerides isolated from roots of Moringa stenopetala. Med Chem Res. 22:4592–4599.10.1007/s00044-013-0467-x
- Bruno de Sousa C, Gangadhar KN, Morais TR, Conserva GA, Vizetto-Duarte C, Pereira H, Laurenti MD, Campino L, Levy D, Uemi M, et al. 2017a. Antileishmanial activity of meroditerpenoids from the macroalgae C. baccata. Exp Parasitol. 174:1–9.10.1016/j.exppara.2017.01.002
- Bruno de Sousa C, Gangadhar KN, Macridachis J, Pavão M, Morais TR, Campino L, Varela J, Lago JHG. 2017b. Cystoseira algae (Fucaceae): update on their chemical entities and biological activities. Tetrahedron: Asymmetry. 28:1486–1505.https://doi.org/10.1016/j.tetasy.2017.10.014.
- Gray CA, de Lira SP, Silva M, Pimenta EF, Thiemann OH, Oliva G, Hajdu E, Andersen RJ, Berlinck RGS. 2006. Sulfated meroterpenoids from the Brazilian sponge Callyspongia sp. are inhibitors of the antileishmaniasis target adenosine hosphoribosyltransferase. J Org Chem. 71:8685–8690.10.1021/jo060295k
- Kahla-Nakbi A, Haouas N, Ouaer AE, Guerbej H, Mustapha KB, Babba H. 2010. Screening of antileishmanial activity from marine sponge extracts collected off the Tunisian coast. Parasitol Res. 106:1281–1286.10.1007/s00436-010-1818-x
- Lockshin RA, Zakeri Z. 2004. Apoptosis, autophagy, and more. Int J Biochem Cell Biol. 36:2405–2419.10.1016/j.biocel.2004.04.011
- Monte Neto RL, Sousa LMA, Dias CS, Barbosa Filho JM, Oliveira MR, Figueiredo RCBQ. 2011. Morphological and physiological changes in Leishmania promastigotes induced by yangambin, a lignan obtained from Ocotea duckei. Exp Parasitol. 127:215–221.10.1016/j.exppara.2010.07.020
- Reyes C, Zbakh H, Motilva V, Zubía E. 2013. Antioxidant and anti-inflammatory meroterpenoids from the brown alga Cystoseira usneoides. J Nat Prod. 76:621–629.10.1021/np300833y
- Rodrigues A, Farias L, Carvalho A, Santos A, Nascimento J, Silva E. 2014. A novel function for kojic acid, a secondary metabolite from Aspergillus fungi, as antileishmanial agent. PLoS One. 9:e91259.10.1371/journal.pone.0091259
- Spavieri J, Allmendinger A, Kaiser M, Casey R, Hingley-Wilson S, Lalvani A, Guiry MD, Blunden G, Tasdemir D. 2010. Antimycobacterial, antiprotozoal and cytotoxic potential of twenty-one brown algae (phaeophyceae) from British and Irish waters. Phytother Res. 24:1724–1729.10.1002/ptr.v24:11
- Sundar S, Chakravarty J. 2015. Investigational drugs for visceral leishmaniasis. Expert Opin Investig Drugs. 20:43–59.10.1517/13543784.2014.954035
- Süzgeç-Selçuk S, Meriçli AH, Güven KC, Casey R, Hingley-Wilson S, Lalvani A, Guiry MD, Blunden G, Tasdemir D. 2010. Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities. Phytother Res. 25:778–783.
- Tempone AG, Martins de Oliveira C, Berlinck RG. 2011. Current approaches to discover marine antileishmanial natural products. Planta Med. 77:572–585.10.1055/s-0030-1250663
- Vassallo O, Castelli S, Biswas A, Sengupta S, Das PK, D’Annessa I, Oteri F, Leoni A, Tagliatesta P, Majumder HK, et al. 2011. Conjugated eicosapentaenoic acid (cEPA) inhibits L. donovani topoisomerase I and has an antiproliferative activity against L. donovani promastigotes. Open Antimicrob Ag J. 3:23–29.
- Yamthe LR, Appiah-Opong R, Fokou PVT, Tsabang N, Boyom FF, Nyarko AK, Wilson MD. 2017. Marine algae as source of novel antileishmanial drugs: a review. Mar Drugs. 15:323.10.3390/md15110323